Occult hepatitis B virus infection in Sudan: A systematic review and meta‐analysis Occult hepatitis B virus infection in Sudan: A systematic review and meta‐analysis - Eltom - 2020 - JGH Open - Wiley Online Library Working off-campus? Learn about our By continuing to browse this site, you agree to its use of cookies as described in our . Search within Search term Search term Review Article Open Access Occult hepatitis B virus infection in Sudan: A systematic review and meta‐analysis (...) infection (OBI) is defined as the presence of HBV‐DNA in the liver (with detectable or undetectable HBV‐DNA in the serum) of individuals testing HBsAg negative by currently available assays. OBI can manifest in four forms of clinical conditions: recovery from past infection indicated by the presence of hepatitis B surface antibodies (anti‐HBs); chronic hepatitis with surface gene escape mutants that are not recognized by current assays; chronic carriage without any marker of HBV infection other than HBV

Risk factors for the development of hepatocellular carcinoma (HCC) in chronic hepatitis B virus (HBV) infection: a systematic review and meta-analysis Risk factors for the development of hepatocellular carcinoma (HCC) in chronic hepatitis B virus (HBV) infection: a systematic review and meta-analysis | medRxiv Search for this keyword Risk factors for the development of hepatocellular carcinoma (HCC) in chronic hepatitis B virus (HBV) infection: a systematic review and meta-analysis Cori (...) For correspondence: Abstract Background Hepatocellular carcinoma (HCC) is one of the leading contributors to cancer mortality worldwide and is the largest cause of death in individuals with chronic hepatitis B virus (HBV) infection. It is not certain how the presence of other metabolic factors and comorbidities influences HCC risk in HBV. Therefore we performed a systematic review and meta-analysis to seek evidence for significant associations. Methods MEDLINE, Embase and Web of Science databases were searched

Effect of Liuweiwuling (LWWL) tablet on biochemical and virological parameters, and quality of life in patients with hepatitis B virus-related cirrhosis: protocol for a systematic review and meta-analysis Inplasy Protocol 608 - INPLASY.COM International Platform of Registered Systematic Review and Meta-analysis Protocols Main Menu Share this: Copyright © 2021 INPLASY.COM Powered by INPLASY.COM

Bulevirtide (Hepcludex) - chronic (long-term) hepatitis delta virus (HDV) Official address Domenico Scarlattilaan 6 ? 1083 HS Amsterdam ? The Netherlands An agency of the European Union Address for visits and deliveries Refer to www.ema.europa.eu/how-to-find-us Send us a question Go to www.ema.europa.eu/contact Telephone +31 (0)88 781 6000 © European Medicines Agency, 2020. Reproduction is authorised provided the source is acknowledged. EMA/312782/2020 EMEA/H/C/004854 Hepcludex (bulevirtide (...) ) An overview of Hepcludex and why it is authorised in the EU What is Hepcludex and what is it used for? Hepcludex is an antiviral medicine used to treat chronic (long-term) hepatitis delta virus (HDV) infection in adults with compensated liver disease (when the liver is damaged but is still able to work), when the presence of viral RNA (genetic material) has been confirmed by blood tests. HDV is an 'incomplete' virus, because it cannot replicate in cells without the help of another virus, the hepatitis B

Utilization of hepatitis C virus-infected organ donors in cardiothoracic transplantation: An ISHLT expert consensus statement Utilization of hepatitis C virus–infected organ donors in cardiothoracic transplantation: An ISHLT expert consensus statement - The Journal of Heart and Lung Transplantation Go search , P418-432, May 01, 2020 Powered By Mendeley Share on Utilization of hepatitis C virus–infected organ donors in cardiothoracic transplantation: An ISHLT expert consensus statement Saima (...) Jeffrey Teuteberg,MD Maria Crespo,MD Haifa Lyster,PharmD Laura Lourenco,PharmD Sara Machado,MD Michael Shullo,Pharm D Matthew Hartwig,MD Miranda Peraskeva,MD Cameron Wolfe,MD Kiran Khush,MD Michael Ison,MD Shelley Hall,MD Joshua Mooney,MD Steve Ivulich,PharmD Marcelo Cypel,MD Victor Pretorius,MBBS Patricia Uber,PharmD Evan Kransdorf,MD, PhD Adam Cochrane,PharmD, MPH Alan Glanville,MD Jennifer Gray,PharmD Published: March 18, 2020 DOI: The advent of therapies for successful treatment of hepatitis C

Cessation of nucleos(t)ide analogues therapy in chronic hepatitis B: a systematic review and meta-analysis Cessation of nucleos(t)ide analogues therapy in chronic hepatitis B: a systematic review and meta-analysis | Research Square Browse Tools & Services Your Cart This is a preprint, a preliminary version of a manuscript that has not completed peer review at a journal. Research Square does not conduct peer review prior to posting preprints. The posting of a preprint on this server should (...) not be interpreted as an endorsement of its validity or suitability for dissemination as established information or for guiding clinical practice. Research article Cessation of nucleos(t)ide analogues therapy in chronic hepatitis B: a systematic review and meta-analysis Yandi Xie, Rui Jin, Guangjun Song, Hui Ma, Bo Feng Yandi Xie Peking University People's Hospital ORCiD: https://orcid.org/0000-0001-5002-341X Rui Jin Peking University People's Hospital Guangjun Song Peking University People's Hospital Hui Ma

Comparison of renal safety of Telbivudine and Entecavir in Chronic Hepatitis B patients with renal impairment: A meta-analysis Comparison of renal safety of Telbivudine and Entecavir in Chronic Hepatitis B patients with renal impairment: A meta-analysis | Research Square Browse Tools & Services Your Cart This is a preprint, a preliminary version of a manuscript that has not completed peer review at a journal. Research Square does not conduct peer review prior to posting preprints. The posting (...) of a preprint on this server should not be interpreted as an endorsement of its validity or suitability for dissemination as established information or for guiding clinical practice. Research Comparison of renal safety of Telbivudine and Entecavir in Chronic Hepatitis B patients with renal impairment: A meta-analysis Birong Huang, Shasha Ma, Jizhou Wu Birong Huang Guangxi Medical University First Affiliated Hospital ORCiD: https://orcid.org/0000-0003-2663-0978 Shasha Ma Guangxi Medical University First

A Meta–Analysis and Systematic Review to Determine the Pregnancy Outcomes in Mothers with inactive Hepatitis B Carrier A Meta–Analysis and Systematic Review to Determine the Pregnancy Outcomes in Mothers with inactive Hepatitis B Carrier | Annals of Gulf Medicine Open Menu Search Search / / / Articles Keywords: Inactive hepatitis B, Pregnancy, adverse effects on pregnancy Abstract Objective: Our goal was to investigate whether asymptomatic maternal hepatitis B (HB) infection affects early (...) to modify using statistical methods such as subgroup analysis in this chapter. Conclusion: Inactive HB infection did not increase the risk of adverse effects in this study. In addition, well-designed tests should be performed to confirm the results. Published 2020-07-22 How to Cite Badar, S., Javed, Z. ., & Ayesha, G. (2020). A Meta–Analysis and Systematic Review to Determine the Pregnancy Outcomes in Mothers with inactive Hepatitis B Carrier. Annals of Gulf Medicine , 2 (1). https://doi.org/10.37978

USPSTF recommends screening adults 18 to 79 years for hepatitis C virus infection (moderate certainty). Owens DK, Davidson KW, Krist AH, et al. Screening for hepatitis C virus infection in adolescents and adults: US Preventive Services Task Force Recommendation Statement. JAMA. 2020;323:970-5. 32119076.

Concurrent hepatic steatosis increases the risk of hepatocellular carcinoma in patients with chronic hepatitis B or C virus infection: a systematic review and meta-analysis Inplasy Protocol 563 - INPLASY.COM International Platform of Registered Systematic Review and Meta-analysis Protocols Main Menu Share this: Copyright © 2021 INPLASY.COM Powered by INPLASY.COM

Systematic review of health state utility values used in European pharmacoeconomic evaluations for chronic hepatitis C: impact on cost-effectiveness results Systematic review of health state utility values used in pharmacoeconomic evaluations for chronic hepatitis C: impact on cost-effectiveness results | medRxiv Search for this keyword Systematic review of health state utility values used in pharmacoeconomic evaluations for chronic hepatitis C: impact on cost-effectiveness results Ru Han (...) used in pharmacoeconomic evaluations for chronic hepatitis C (CHC) and are particularly instrumental in health technology assessment (HTA) evaluation like the National Institute for Health and Clinical Excellence (NICE). Objective The objective of this study is to identify HSUVs used in cost-utility analyses (CUAs) for CHC in Europe and evaluate the impact of HSUVs selection on cost-effectiveness results in terms of incremental cost per quality-adjusted life-year (QALY) gained (ICER). Methods

The Association Between Hepatitis C Virus Infection and Renal Cell Cancer, Prostate Cancer, and Bladder Cancer: A Systematic Review and Meta-Analysis The Association Between Hepatitis C Virus Infection and Renal Cell Cancer, Prostate Cancer, and Bladder Cancer: A Systematic Review and Meta-Analysis | Research Square Browse Tools & Services Your Cart This is a preprint, a preliminary version of a manuscript that has not completed peer review at a journal. Research Square does not conduct peer (...) review prior to posting preprints. The posting of a preprint on this server should not be interpreted as an endorsement of its validity or suitability for dissemination as established information or for guiding clinical practice. Research article The Association Between Hepatitis C Virus Infection and Renal Cell Cancer, Prostate Cancer, and Bladder Cancer: A Systematic Review and Meta-Analysis Zhongyu Jian, Yucheng Ma, Hong Li, Kunjie Wang Zhongyu Jian department of urology, institute of urology

Pregnancy for patients with autoimmune hepatitis: a systematic review and meta-analysis Inplasy Protocol 386 - INPLASY.COM International Platform of Registered Systematic Review and Meta-analysis Protocols Main Menu Share this: Copyright © 2021 INPLASY.COM Powered by INPLASY.COM

Is the universal population Hepatitis C virus screening a cost-effective strategy? A systematic review of the economic evidence Rev Esp Quimioter 2020; 33(4): 240-248 – SEQ , Is the universal population Hepatitis C virus screening a cost-effective strategy? A systematic review of the economic evidence FRANCISCO LEDESMA, MARÍA BUTI, RAQUEL DOMÍNGUEZ-HERNÁNDEZ, MIGUEL ÁNGEL CASADO, RAFAEL ESTEBAN Published: 8 June 2020 Background . Efficient strategies are needed in order to achieve the objective (...) of the WHO of eradicating Hepatitis C virus (HCV). Hepatitis C infection can be eliminated by a combination of direct acting antiviral (DAA). The problem is that many individuals remain undiagnosed. The objective is to conduct a systematic review of the evidence on economic evaluations that analyze the screening of HCV followed by treatment with DAAs. Methods. Eleven databases were performed in a 2015-2018-systematic review. Inclusion criteria were economic evaluations that included incremental cost

Hepatitis C Virus Infection in Adolescents and Adults: Screening Recommendation | United States Preventive Services Taskforce Toggle navigation Main navigation Main navigation Recommendation Adults aged 18 to 79 years The USPSTF recommends screening for hepatitis C virus (HCV) infection in adults aged 18 to 79 years. B View the Clinical Summary in What does the USPSTF recommend? For adults aged 18 to 79 years: Grade B Screen adults for hepatitis C virus (HCV) infection. To whom does (...) evidence to determine how often to screen persons at increased risk. What are other relevant USPSTF recommendations? The USPSTF has made recommendations on screening for hepatitis B virus infection in pregnant persons, hepatitis B virus infection in adults, and HIV infection. These recommendations are available at . Where to read the full recommendation statement? Visit the USPSTF website to read the full recommendation statement. This includes more details on the rationale of the recommendation

Systematic Review of the Management of Retro-Hepatic Inferior Vena Cava Injuries

Systematic Review of the Management of Retro-Hepatic Inferior Vena Cav | OAEM Javascript is currently disabled in your browser. Several features of this site will not function whilst javascript is disabled. open access to scientific and medical research Journal Email Alerts About Dove Press Open access peer-reviewed scientific and medical journals. Open Access Dove Medical Press is a member of the OAI (...) . Reprints Bulk reprints for the pharmaceutical industry. Favored Authors We offer real benefits to our authors, including fast-track processing of papers. Promotional Article Monitoring Register your specific details and specific drugs of interest and we will match the information you provide to articles from our extensive database and email PDF copies to you promptly. Social Media Back to » » Review Systematic Review of the Management of Retro-Hepatic Inferior Vena Cava Injuries Authors Zargaran D

Entecavir in the treatment of chronic hepatitis B in children and adolescents:Systematic review and meta-analysis Inplasy Protocol 345 - INPLASY.COM International Platform of Registered Systematic Review and Meta-analysis Protocols Main Menu Share this: Copyright © 2021 INPLASY.COM Powered by INPLASY.COM

Seroepidemiology of Hepatitis E Virus Infection in Patients Undergoing Maintenance Hemodialysis: A Systematic Review and Meta‐Analysis Seroepidemiology of hepatitis E virus infection in patients undergoing maintenance hemodialysis: Systematic review and meta‐analysis - Tavakoli - 2021 - Therapeutic Apheresis and Dialysis - Wiley Online Library Working off-campus? Learn about our By continuing to browse this site, you agree to its use of cookies as described in our . Search within Search term (...) Search term REVIEW Free Access Seroepidemiology of hepatitis E virus infection in patients undergoing maintenance hemodialysis: Systematic review and meta‐analysis Department of Medical Virology, Faculty of Medicine, Iran University of Medical Sciences, Tehran, Iran Baqiyatallah Research Center for Gastroenterology and Liver Diseases (BRCGL), Baqiyatallah University of Medical Sciences, Tehran, Iran Middle East Liver Disease (MELD) Center, Tehran, Iran Department of Microbiology, Faculty of Medicine

The Strategy and Efficacy of Prophylaxis Against Hepatitis B Virus Recurrence After Liver Transplantation in the Era of High Potent Nucleos(t)ide Analogues: A Meta-Analysis The Strategy and Efficacy of Prophylaxis Against Hepatitis B Virus Recurrence After Liver Transplantation in the Era of High Potent Nucleos(t)ide Analogues: A Meta-Analysis | Research Square Browse Tools & Services Your Cart This is a preprint, a preliminary version of a manuscript that has not completed peer review (...) at a journal. Research Square does not conduct peer review prior to posting preprints. The posting of a preprint on this server should not be interpreted as an endorsement of its validity or suitability for dissemination as established information or for guiding clinical practice. Research The Strategy and Efficacy of Prophylaxis Against Hepatitis B Virus Recurrence After Liver Transplantation in the Era of High Potent Nucleos(t)ide Analogues: A Meta-Analysis Mingshu Li, Zhouhua Hou, Guozhu Yao, Deming Tan

The Association Between Hepatitis C Virus Infection and Renal Cell Cancer, Prostate Cancer, and Bladder Cancer: A Systematic Review and Meta-Analysis Inplasy Protocol 319 - INPLASY.COM International Platform of Registered Systematic Review and Meta-analysis Protocols Main Menu Share this: Copyright © 2021 INPLASY.COM Powered by INPLASY.COM